Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:dexmedetomidine
|
| gptkbp:approvedBy |
gptkb:FDA
1999 procedural sedation sedation of initially intubated and mechanically ventilated patients |
| gptkbp:ATCCode |
gptkb:N05CM18
|
| gptkbp:contraindication |
advanced heart block
severe ventricular dysfunction |
| gptkbp:form |
solution for injection
|
| gptkbp:halfLife |
2 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Precedex
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:Japan gptkb:United_States |
| gptkbp:mechanismOfAction |
alpha-2 adrenergic agonist
|
| gptkbp:pregnancyCategory |
Not assigned (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
hypotension dry mouth bradycardia |
| gptkbp:usedFor |
sedation
|
| gptkbp:usedIn |
intensive care unit
|
| gptkbp:bfsParent |
gptkb:Hospira
|
| gptkbp:bfsLayer |
5
|